SteelPeak Wealth LLC Acquires 13,533 Shares of UnitedHealth Group Incorporated $UNH

Key Points

• SteelPeak Wealth increased its UnitedHealth Group stake by 41.9% in the third quarter, acquiring 13,533 shares for a total holding of 45,834 shares valued at approximately $16.8 million. Institutional investors collectively own 87.86% of UNH.
• UnitedHealth’s third-quarter results exceeded expectations, with adjusted EPS of $4.69 and revenue of $112.7 billion; management raised its 2026 adjusted EPS guidance to at least $20.50. Analysts remain broadly positive, with a consensus “Moderate Buy” rating and a $462.90 price target.
• Risks remain around the recovery: membership declined, medical costs and utilization stayed elevated, and some analysts lowered targets or maintained “hold” ratings, questioning the durability of earnings and margin improvements.

SteelPeak Wealth LLC raised its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 41.9% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 45,834 shares of the healthcare conglomerate's stock after acquiring an additional 13,533 shares during the quarter. SteelPeak Wealth LLC's holdings in UnitedHealth Group were worth $16,825,000 at the end of the most recent quarter.

A number of other large investors also recently made changes to their positions in UNH. General Partner Inc. purchased a new stake in UnitedHealth Group in the 3rd quarter worth approximately $512,000. PBCay One RSC Ltd acquired a new stake in shares of UnitedHealth Group during the 1st quarter valued at $14,343,000. Lee Johnson Capital Management LLC purchased a new position in shares of UnitedHealth Group during the 2nd quarter valued at $6,180,000. Kinsale Capital Group Inc. increased its stake in shares of UnitedHealth Group by 13.4% in the second quarter. Kinsale Capital Group Inc. now owns 38,510 shares of the healthcare conglomerate's stock worth $16,006,000 after acquiring an additional 4,557 shares during the last quarter. Finally, Fideuram Intesa Sanpaolo Private Banking S.P.A. increased its stake in shares of UnitedHealth Group by 1,287.2% in the first quarter. Fideuram Intesa Sanpaolo Private Banking S.P.A. now owns 60,022 shares of the healthcare conglomerate's stock worth $16,241,000 after acquiring an additional 55,695 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.

Insider Buying and Selling

In other UnitedHealth Group news, CEO Patrick Conway sold 1,169 shares of the stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $390.00, for a total transaction of $455,910.00. Following the transaction, the chief executive officer owned 15,328 shares in the company, valued at $5,977,920. This trade represents a 7.09% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 0.19% of the stock is currently owned by company insiders.

Key Headlines Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Q3 results and guidance exceeded expectations. UnitedHealth reported adjusted earnings of $4.69 per share versus the $4.14 consensus estimate, while revenue of $112.7 billion also topped forecasts. Management raised its 2026 adjusted EPS outlook to at least $20.50, supporting the recovery narrative. UnitedHealth Stock Moves Higher: What's Going On?
• Positive Sentiment: Analyst support remains significant. JPMorgan raised its price target to $524 and maintained an “overweight” rating, while Goldman Sachs reportedly lifted its target to $506 after concluding that Medicare Advantage margin recovery is progressing faster than expected. JPMorgan Raises UnitedHealth Price Target
• Positive Sentiment: Potential growth areas could support 2027 and beyond. UnitedHealth’s focus on Medicare special-needs plans, expanded coverage and care-delivery operations may provide targeted growth while improving margins. Its low beta also makes UNH attractive as a defensive healthcare holding during inflation and market rotation away from technology stocks. Can UNH's Focus on Special Needs Plans Strengthen Medicare Growth?
• Neutral Sentiment: Recent gains may have already priced in much of the good news. Commentary noted that the earnings beat and outlook increase were followed by questions about how durable the recovery will be, limiting the immediate upside despite bullish targets. UnitedHealth Beats on Earnings, But Investors Question Growth Path
• Negative Sentiment: Membership fell and medical costs remain high. Analysts are concerned that shrinking membership and elevated utilization could constrain revenue growth and margins, particularly if higher care costs persist. This is the main reason investors are questioning whether the earnings improvement can continue. UnitedHealth's Q3 Margins Improve, But Membership Falls
• Negative Sentiment: Analyst views are mixed. Barclays issued a pessimistic forecast, Robert W. Baird cut its price target, and TD Cowen reiterated a “hold” rating with a $402 target, signaling limited near-term upside for some investors.

UnitedHealth Group Price Performance

NYSE UNH opened at $401.77 on Friday. UnitedHealth Group Incorporated has a fifty-two week low of $255.96 and a fifty-two week high of $461.62. The stock's 50-day moving average is $387.07 and its two-hundred day moving average is $384.64. The firm has a market cap of $360.62 billion, a P/E ratio of 22.95, a price-to-earnings-growth ratio of 1.45 and a beta of 0.60. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.74 and a quick ratio of 0.78.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.14 by $0.55. UnitedHealth Group had a return on equity of 17.95% and a net margin of 3.53%. The company had revenue of $112.70 billion during the quarter, compared to the consensus estimate of $111.31 billion. During the same quarter in the prior year, the company posted $2.59 EPS. The firm's revenue was down .4% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. On average, analysts anticipate that UnitedHealth Group Incorporated will post 20.64 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 22nd. Shareholders of record on Monday, September 14th were given a dividend of $2.32 per share. The ex-dividend date of this dividend was Monday, September 14th. This represents a $9.28 dividend on an annualized basis and a yield of 2.3%. UnitedHealth Group's dividend payout ratio is presently 53.00%.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on UNH. Erste Group Bank cut UnitedHealth Group from a "buy" rating to a "hold" rating in a research report on Thursday, August 27th. Oppenheimer upped their target price on UnitedHealth Group from $420.00 to $500.00 and gave the stock an "outperform" rating in a research report on Friday, July 17th. Stephens set a $500.00 price target on UnitedHealth Group in a research note on Friday. New Street Research set a $402.00 price target on UnitedHealth Group in a report on Friday, October 9th. Finally, Leerink Partners boosted their price target on UnitedHealth Group from $462.00 to $472.00 and gave the company an "outperform" rating in a research note on Friday, July 17th. Twenty investment analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company. Based on data from MarketBeat, UnitedHealth Group presently has a consensus rating of "Moderate Buy" and a consensus target price of $462.90.

UnitedHealth Group Profile

UnitedHealth Group Incorporated NYSE: UNH is a diversified health care company that provides health insurance coverage, health care services, pharmacy services and health technology. Its businesses serve individuals, employers, government programs, health care providers and other organizations, primarily in the United States.

The company operates through two principal businesses. UnitedHealthcare offers health benefit plans and related services for employers, individuals, families and government-sponsored programs, including Medicare and Medicaid.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.